Evidence map›Paper›PMID 23790486›Full record

ArticleChemistry & biology2013

Juxtaposition of chemical and mutation-induced developmental defects in zebrafish reveal a copper-chelating activity for kalihinol F.

Imelda T Sandoval, Elizabeth J Manos, Ryan M Van Wagoner, Richard Glenn C Delacruz, Kornelia Edes, Dennis R Winge, Chris M Ireland, David A Jones

Abstract read
In one paragraph

Article in Chemistry & biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Stereocontrolled Synthesis of Kalihinol C.Journal of the American Chemical Society · 2017
    Article
  7. Review
  8. Article
  9. Article
  10. Zebrafish as tools for drug discovery.Nature reviews. Drug discovery · 2015
    Review
  11. Review
  12. 15 years of zebrafish chemical screening.Current opinion in chemical biology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Imelda T SandovalDepartment of Oncological Sciences, University of Utah, Salt Lake City, UT 84112, USA.
Elizabeth J Manos
Ryan M Van Wagoner
Richard Glenn C Delacruz
Kornelia Edes
Dennis R Winge
Chris M Ireland
David A Jones

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jared P Rutter · 1986 to 2026
$72.6M
TCF/LEF function during intestinal maintenance and colon tumorigenesisP01CA073992 · NCI · UNIVERSITY OF UTAH · PI NEKLASON, DEBORAH WOOD · 1998 to 2014
$29.7M
APC and Retinoids in Zebrafish Enterocyte DevelopmentR01CA116468 · NCI · UNIVERSITY OF UTAH · PI JONES, DAVID A · 2005 to 2020
$4.2M
ANTINEOPLASTIC AGENTS FROM MARINE ORGANISMSR01CA036622 · NCI · UNIVERSITY OF UTAH · PI IRELAND, CHRIS M. · 1985 to 2010
$3.0M
ACQUISTION OF A 300 MHZ NMR SPECTROMETERS10RR014768 · NCRR · UNIVERSITY OF UTAH · PI PRESTWICH, GLENN D · 2000 to 2000
$215k
500 MHZ NMR SPECTROMETERS10RR006262 · NCRR · UNIVERSITY OF UTAH · PI IRELAND, CHRIS M. · 1991 to 1991
–
NCI NIH HHS 5P01CA073992-14NCI NIH HHS 5R01CA116468-08NCI NIH HHS CA36622NCI NIH HHS P01 CA073992NCI NIH HHS P30 CA042014NCI NIH HHS R01 CA036622NCI NIH HHS R01 CA116468NCRR NIH HHS RR06262NCRR NIH HHS RR14768
6 · The paper itself

Abstract

A major hurdle in using complex systems for drug screening is the difficulty of defining the mechanistic targets of small molecules. The zebrafish provides an excellent model system for juxtaposing developmental phenotypes with mechanism discovery using organism genetics. We carried out a phenotype-based screen of uncharacterized small molecules in zebrafish that produced a variety of chemically induced phenotypes with potential genetic parallels. Specifically, kalihinol F caused an undulated notochord, defects in pigment formation, hematopoiesis, and neural development. These phenotypes were strikingly similar to the zebrafish mutant, calamity, an established model of copper deficiency. Further studies into the mechanism of action of kalihinol F revealed a copper-chelating activity. Our data support this mechanism of action for kalihinol F and the utility of zebrafish as an effective system for identifying therapeutic and target pathways.

Indexed as

AnimalsCell SurvivalChelating AgentsCopperDiterpenesEmbryo, NonmammalianGene Expression Regulation, DevelopmentalHep G2 CellsHumansMutationNitrilesNotochordPhenotypeZebrafishChelating AgentsCoppercupric chlorideDiterpeneskalihinol FNitriles

Identifiers

PMID23790486
PMCPMC3715381

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.